Garry R. Smith
Garry R. Smith publishes mostly in Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Carbohydrate Chemistry and Synthesis, Chemical Synthesis and Analysis and Neuroscience and Neuropharmacology Research.
- World rank
- #4,035,957 of 7,710,434 ranked researchers
- Rank in United States
- #1,098,921 of 1,627,098
- Works
- 54
- Citations
- 1.4k
- Citations per work
- 25.6
What does Garry R. Smith research?
Garry R. Smith's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Chemistry (25%), Neuroscience (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1935.8%
- Everything else1731.7%
- Physical Sciences1425.2%
- Chemistry1425.2%
- Health Sciences47.3%
- Medicine47.3%
- 1Organic Chemistry25% of their works
- 2Molecular Biology23% of their works
- 3Cellular and Molecular Neuroscience9% of their works
- 4Neurology4% of their works
- 5Cancer Research4% of their works
- 6Oncology3% of their works
Research topics
- Carbohydrate Chemistry and Synthesis
- Chemical Synthesis and Analysis
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Synthesis and Biological Activity
- Biochemical and Molecular Research
- Botulinum Toxin and Related Neurological Disorders
- Viral-associated cancers and disorders
Which keywords describe Garry R. Smith's research?
The keywords of their largest research topics: Glycosidase Inhibitors, Oligosaccharide Synthesis, Drug Discovery, Peptide Synthesis, Neurological Disorders, Dopamine, Neurotransmission and Serotonin.
- Nucleotide Metabolism
- Kaposi's Sarcoma
- Enzyme Regulation
- Botulinum Toxin
- Serotonin
- Dopamine
- Peptide Synthesis
- Oligosaccharide Synthesis
- Glycosidase Inhibitors
- Drug Discovery
- Neurological Disorders
- Neurotransmission
- Synaptic Plasticity
- Ecteinascidin
- Epstein-Barr Virus
- Neurotoxins
- Tetrahydroisoquinoline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Glycosidase Inhibitors111 topic
- Oligosaccharide Synthesis111 topic
- Drug Discovery101 topic
- Peptide Synthesis101 topic
- Neurological Disorders92 topics
- Dopamine51 topic
- Neurotransmission51 topic
- Serotonin51 topic
- Synaptic Plasticity51 topic
- Botulinum Toxin41 topic
- Ecteinascidin41 topic
- Enzyme Regulation41 topic
- Epstein-Barr Virus41 topic
- Kaposi's Sarcoma41 topic
- Neurotoxins41 topic
- Nucleotide Metabolism41 topic
- Tetrahydroisoquinoline41 topic
Where does Garry R. Smith work?
Garry R. Smith's main affiliation in the publication record is Fox Chase Chemical Diversity Center, United States.
How many publications and citations does Garry R. Smith have?
OpenAlex counts 54 works and 1,385 citations for Garry R. Smith, an h-index of 19, ranking #4,035,957 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Garry R. Smith. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.